• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA• Launch preparations are underway to bring the second approved golimumab biosimilar to patients acro...
View Details•Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia®developed by Bio-Thera and to be marketed by STADA•Recommendation from EMA’s CHMP committee is based on a robust analytical, non-clinical and clinica...
Guangzhou, China; November 10, 2025: Bio-TheraSolutions (688177:SH; “Bio-Thera”), a commercial-stage biopharmaceuticalcompany developing a pipeline of innovative therapies and biosimilars, today announcedthat it has entered into an exclusive commerci...
GUANGZHOU,China - Bio-Thera Solutions (688177.SH), a commercial-stage biopharmaceutical companydeveloping innovative therapies and biosimilars, announced that its partner, HikmaPharmaceuticals USA Inc. officially launched STARJEMZA® (ustekinumab-hmny...
